{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:05:44Z","timestamp":1792652744450,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijrobp.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T20:29:48Z","timestamp":1529440188000},"page":"794-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group"],"prefix":"10.1016","volume":"101","author":[{"given":"Richard W.","family":"Tsang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant S.","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris R.","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia M.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ok","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Mauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.05.009_bib1","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib3","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood-2014-04-567909","article-title":"Multiparameter flow cytometry for staging of solitary bone plasmacytoma: New criteria for risk of progression to myeloma","volume":"124","author":"Paiva","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2014-04-566521","article-title":"Outcome prediction in plasmacytoma of bone: A risk model utilizing bone marrow flow cytometry and light-chain analysis","volume":"124","author":"Hill","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","article-title":"Solitary plasmacytoma: Population-based analysis of survival trends and effect of various treatment modalities in the USA","volume":"17","author":"Thumallapally","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2005.06.039","article-title":"Outcomes and patterns of failure in solitary plasmacytoma: A multicenter rare cancer Network study of 258 patients","volume":"64","author":"Ozsahin","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2013-03-487025","article-title":"Outcomes of patients with POEMS syndrome treated initially with radiation","volume":"122","author":"Humeniuk","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/028418600750063578","article-title":"Imaging of myeloma bone disease\u2014implications for staging, prognosis and follow-up","volume":"39","author":"Dimopoulos","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1102\/1470-7330.2010.0013","article-title":"Multiple myeloma","volume":"10","author":"Collins","year":"2010","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib10","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: Report of the international myeloma Workshop consensus panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2014.57.9961","article-title":"Role of magnetic resonance imaging in the management of patients with multiple myeloma: A consensus statement","volume":"33","author":"Dimopoulos","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib12","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: A consensus statement by the international myeloma working group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib13","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/cncr.26467","article-title":"18F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: A systematic review","volume":"118","author":"van Lammeren-Venema","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjh.12346","article-title":"Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: A systematic review","volume":"162","author":"Regelink","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/RLU.0b013e31825b2071","article-title":"FDG PET or PET\/CT for detecting intramedullary and extramedullary lesions in multiple myeloma: A systematic review and meta-analysis","volume":"37","author":"Lu","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/108497803770418382","article-title":"Positron emission tomography (PET) for staging of solitary plasmacytoma","volume":"18","author":"Schirrmeister","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/j.semnuclmed.2007.07.002","article-title":"18F-Fluoride positron emission tomography and positron emission tomography\/computed tomography","volume":"37","author":"Even-Sapir","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib18","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/j.ejrad.2012.06.028","article-title":"Contrast enhanced MRI and 18F-FDG PET-CT in the assessment of multiple myeloma: A comparison of results in different phases of the disease","volume":"81","author":"Spinnato","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(96)00334-3","article-title":"Solitary plasmacytoma of\u00a0bone and soft tissue","volume":"36","author":"Bolek","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib20","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ijrobp.2010.11.037","article-title":"Multi-institutional analysis of solitary extramedullary plasmacytoma of the head and neck treated with curative radiotherapy","volume":"82","author":"Sasaki","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0360-3016(00)01572-8","article-title":"Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome","volume":"50","author":"Tsang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0360-3016(98)00186-2","article-title":"Solitary bone plasmacytoma: Outcome and prognostic factors following radiotherapy","volume":"41","author":"Liebross","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib23","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1002\/cncr.26031","article-title":"Solitary plasmacytomas: Outcome and prognostic factors after definitive radiation therapy","volume":"117","author":"Reed","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib24","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3","article-title":"Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts","volume":"85","author":"Alexiou","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2005.09.019","article-title":"Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control","volume":"64","author":"Tournier-Rangeard","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hed.20821","article-title":"Solitary extramedullary plasmacytoma of the head and neck\u2014long-term outcome analysis of 68 cases","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.6004\/jnccn.2017.0023","article-title":"Multiple myeloma, version 3.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Kumar","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","article-title":"Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma","volume":"124","author":"Soutar","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.36076\/ppj.2011\/14\/447","article-title":"The use of vertebral augmentation and external beam radiation therapy in the multimodal management of malignant vertebral compression fractures","volume":"14","author":"Hirsch","year":"2011","journal-title":"Pain Physician"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00270-011-0111-4","article-title":"Percutaneous vertebroplasty in multiple myeloma: Prospective long-term follow-up in 106 consecutive patients","volume":"35","author":"Anselmetti","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.rcl.2008.05.005","article-title":"Percutaneous vertebral augmentation: Vertebroplasty, kyphoplasty, and skyphoplasty","volume":"46","author":"Peh","year":"2008","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib32","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.12659\/MSM.898463","article-title":"Cause analysis of open surgery used after percutaneous vertebroplasty and kyphoplasty","volume":"22","author":"Xu","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.12741","article-title":"Interventional radiology in bone metastases","volume":"26","author":"Chiras","year":"2017","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1200\/JCO.1993.11.7.1311","article-title":"Magnetic resonance imaging in the staging of solitary plasmacytoma of bone","volume":"11","author":"Moulopoulos","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/(SICI)1099-1069(199609)14:3<111::AID-HON575>3.0.CO;2-G","article-title":"Improved outcome in solitary bone plasmacytomata with combined therapy","volume":"14","author":"Aviles","year":"1996","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib36","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4329\/wjr.v5.i6.248","article-title":"Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study","volume":"5","author":"Wiazzane","year":"2013","journal-title":"World J Radiol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0167-8140(90)90003-F","article-title":"The role of radiation therapy in the treatment of solitary plasmacytomas","volume":"17","author":"Mayr","year":"1990","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib38","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.10366","article-title":"Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone","volume":"94","author":"Wilder","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12885-016-2824-x","article-title":"Establishment of an innovative staging system for extramedullary plasmacytoma","volume":"16","author":"Zhu","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0167-8140(99)00114-0","article-title":"Clinical course of solitary extramedullary plasmacytoma","volume":"52","author":"Liebross","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib41","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/bjc.1997.162","article-title":"Extramedullary plasmacytoma of the head and neck region: Clinicopathological correlation in 25 cases","volume":"75","author":"Susnerwala","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib42","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/0360-3016(80)90006-1","article-title":"Solitary plasmacytoma of bone and soft tissue","volume":"6","author":"Mendenhall","year":"1980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0360-3016(02)02780-3","article-title":"Extramedullary plasmacytoma: Clinical and histopathologic study","volume":"53","author":"Strojan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0360-3016(93)90308-I","article-title":"Radiation therapy for the palliation of multiple myeloma","volume":"25","author":"Leigh","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13014-015-0374-z","article-title":"Effects of radiotherapy in the treatment of multiple myeloma: A retrospective analysis of a single institution","volume":"10","author":"Matuschek","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00066-010-2155-9","article-title":"Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: Long-term experience","volume":"187","author":"Balducci","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib47","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","article-title":"International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease","volume":"31","author":"Terpos","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib48","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1200\/JCO.2015.61.9338","article-title":"Survival and clinical outcomes in surgically treated patients with metastatic epidural spinal cord compression: Results of the prospective multicenter AOSpine study","volume":"34","author":"Fehlings","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1515\/raon-2016-0029","article-title":"Excellent outcomes after radiotherapy alone for malignant spinal cord compression from myeloma","volume":"50","author":"Rades","year":"2016","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib51","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12885-016-2325-y","article-title":"A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression","volume":"16","author":"Rades","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib53","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: A report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib54","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: A consensus of the international myeloma working group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib55","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ijrobp.2005.10.018","article-title":"Short-course radiotherapy is not optimal for spinal cord compression due to myeloma","volume":"64","author":"Rades","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib56","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00066-017-1154-5","article-title":"Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma: A prospective randomised study","volume":"193","author":"Rudzianskiene","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib57","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1200\/JCO.2015.64.0862","article-title":"Radiotherapy with 4 Gy x 5 versus 3 Gy x 10 for metastatic epidural spinal cord compression: Final results of the SCORE-2 trial (ARO 2009\/01)","volume":"34","author":"Rades","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib58","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.2016.66.5299","article-title":"Comparing two multifraction spine radiotherapy regimens: Are they really equivalent?","volume":"34","author":"Spratt","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.clml.2014.07.010","article-title":"Feasibility and efficacy of\u00a0local radiotherapy with concurrent novel agents in patients with\u00a0multiple myeloma","volume":"14","author":"Shin","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1179\/joc.2005.17.3.343","article-title":"Severe acute enteritis in a multiple myeloma patient receiving bortezomib and spinal radiotherapy: Case report","volume":"17","author":"Mohiuddin","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.radonc.2007.12.015","article-title":"Concurrent radiation therapy and bortezomib in myeloma patient","volume":"86","author":"Berges","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib62","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2009.07.1715","article-title":"Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies","volume":"78","author":"Pugh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib63","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1748-717X-8-204","article-title":"Concurrent whole brain radiotherapy and bortezomib for brain metastasis","volume":"8","author":"Lao","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib64","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/cncr.26447","article-title":"Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients","volume":"118","author":"Gozzetti","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib65","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/hon.1021","article-title":"Emergence of central nervous system myeloma in the era of novel agents","volume":"30","author":"Gangatharan","year":"2012","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib66","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjh.12414","article-title":"Central nervous system involvement with multiple myeloma: Long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents","volume":"162","author":"Chen","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib67","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0360-3016(97)00558-0","article-title":"Multiple myeloma of an extremity: Must the entire bone be treated?","volume":"40","author":"Catell","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib68","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4329\/wjr.v5.i4.173","article-title":"Volumetric modulated arc radiotherapy for limited osteosclerotic myeloma","volume":"5","author":"Robles","year":"2013","journal-title":"World J Radiol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib70","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.1992.10.4.587","article-title":"Curability of solitary bone plasmacytoma","volume":"10","author":"Dimopoulos","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib71","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.critrevonc.2011.04.006","article-title":"Place of modern imaging modalities for solitary plasmacytoma: Toward improved primary staging and treatment monitoring","volume":"82","author":"Chargari","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib72","first-page":"1","article-title":"Our experience of solitary plasmacytoma of the bone: Improved PFS with a short-course treatment by IMiDs or proteasome inhibitors combined with intensity-modulated radiotherapy","author":"Le Ray","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib74","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2016.8.SPINE16412","article-title":"Spine stereotactic radiosurgery for the treatment of multiple myeloma","volume":"26","author":"Miller","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib75","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood.V99.3.731","volume":"99","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib76","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","article-title":"Targeted total marrow irradiation using three-dimensional image-guided tomographic intensity-modulated radiation therapy: An alternative to standard total body irradiation","volume":"12","author":"Wong","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijrobp.2018.05.009_bib77","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2008.04.071","article-title":"Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation","volume":"73","author":"Wong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"updated-by":[{"DOI":"10.1016\/j.ijrobp.2018.08.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000}}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618308022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301618308022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T20:13:36Z","timestamp":1661458416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301618308022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0360301618308022"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.05.009","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}